Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan

por Ohno-Matsui, Kyoko, Suzaki, Makoto, Teshima, Rie, Okami, Nina
Publicado 2018

Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)

por Sakamoto, Taiji, Shimura, Masahiko, Kitano, Shigehiko, Ohji, Masahito, Ogura, Yuichiro, Yamashita, Hidetoshi, Suzaki, Makoto, Mori, Kimie, Ohashi, Yohei, Yap, Poh Sin, Kaneko, Takeumi, Ishibashi, Tatsuro
Publicado 2021

Two-year visual and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)

por Sakamoto, Taiji, Shimura, Masahiko, Kitano, Shigehiko, Ohji, Masahito, Ogura, Yuichiro, Yamashita, Hidetoshi, Suzaki, Makoto, Mori, Kimie, Kozawa, Masanari, Yap, Poh Sin, Kaneko, Takeumi, Ishibashi, Tatsuro
Publicado 2022